Rabies clinical trials
The registry lists 114 studies for Rabies across more than 10 countries. 15 are recruiting or about to start. 110 of them are mainly about Rabies (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.
Get an email when these change. Save the Rabies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Sanofi Pasteur, a Sanofi Company (13) · Queen Saovabha Memorial Institute (9) · Novartis Vaccines (6) · Synermore Biologics (Suzhou) Co., Ltd. (5) · Sinovac Biotech Co., Ltd (5) · CureVac (3) · Crucell Holland BV (3) · University of Oxford (3)
What is being tested here
Drugs under test in Rabies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5, phase 3 first
- Nov 2026A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years · Phase 3 · Ab&B Bio-tech Co., Ltd.JS
- Dec 2026Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen · Phase 3 · Sinovac Biotech Co., Ltd
- Jan 2027Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen · Phase 3 · Sinovac Biotech Co., Ltd
- May 2027Safety and Immunogenicity of ID vs IM Rabies Vaccine · Phase 3 · International Centre for Diarrhoeal Disease Research, Bangladesh
- Jun 2027Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming. · Phase 3 · Institute of Tropical Medicine, Belgium
Who these studies take
Of the 2 Rabies studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 2 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (100%) | 2 (100%) |
| 18 | 1 (50%) | 1 (50%) |
| 30 | 1 (50%) | 1 (50%) |
| 40 | 1 (50%) | 1 (50%) |
| 50 | 1 (50%) | 1 (50%) |
| 65 | 0 (0%) | 0 (0%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 114 studies, recruiting or not: 67% stop at 75 or younger and 65% at 65; 50% take children; 0% are for women only and 1% for men only; 82% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Rabies studies take
Of 19 phase 3 interventional studies under Rabies, half reached primary completion within 15 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 3 | 15 mo8–21 · 19 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 50 of 114. Browse all 114 → or search them.
- An Expanded Access Program for SYN023 in Rabies TreatmentAvailableNCT07706907
- Real World Evidence Study of SYN023 in Children Exposed to RabiesRecruitingNCT073273071 country
- A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)Enrolling by invitationNCT07500207Phase 31 country
- Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.Not yet recruitingNCT07455318Phase 31 country
- A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal AntibodyNot yet recruitingNCT07445815Phase 21 country
- Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies VaccineNot yet recruitingNCT07416110Phase 31 country
- Safety and Immunogenicity of ID vs IM Rabies VaccineNot yet recruitingNCT07345208Phase 2/31 country
- Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed VaccineNot yet recruitingNCT07168018Phase 21 country
- Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis RegimenNot yet recruitingNCT07055893Phase 31 country
- Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)Not yet recruitingNCT07055880Phase 21 country
- Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis RegimenNot yet recruitingNCT07055295Phase 31 country
- Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)Not yet recruitingNCT07028801Phase 31 country
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-driedRecruitingNCT07021703Phase 11 country
- Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical TrialsNot yet recruitingNCT06548139Phase 21 country
- Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)Not yet recruitingNCT05969626Phase 31 country
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 YearsActive, not recruitingNCT07275645Phase 31 country
- Prevention of Rabies With Four Doses of Rabies VaccineCompletedNCT05545371Phase 31 country
- Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of RabiesCompletedNCT03961555Phase 22 countries
- Study of Intradermal Administration of PCEC Rabies VaccineCompletedNCT01044199Not applicable1 country
- Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in NanyangActive, not recruitingNCT076244611 country
- A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy AdultsCompletedNCT06998004Phase 11 country
- Adherence to Anti-rabies Post-exposure Prophylactic ProtocolsCompletedNCT070120831 country
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of AdultsCompletedNCT04127786Phase 31 country
- Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-driedCompletedNCT07357545Phase 31 country
- SYN023 With Rabies Vaccine in Healthy Pediatric SubjectsCompletedNCT07342257Phase 11 country
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 YearsCompletedNCT06132789Phase 11 country
- A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabGActive, not recruitingNCT04270838Phase 1/21 country
- Survey of Human Rabies Immune Globulin Safety in ChildrenTerminatedNCT053826501 country
- Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in ThaïlandCompletedNCT04478084Phase 31 country
- Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in ThaïlandCompletedNCT04594551Phase 31 country
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in AdultsCompletedNCT03965962Phase 31 country
- A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy AdultsCompletedNCT03713086Phase 12 countries
- Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabGTerminatedNCT04162600Phase 11 country
- Study to Evaluate GR1801's Efficacy and SafetyCompletedNCT05846568Phase 31 country
- A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-driedActive, not recruitingNCT05667974Phase 32 countries
- A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.CompletedNCT02545517Phase 33 countries
- Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult SubjectsCompletedNCT04019444Phase 11 country
- Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and IntradermallyCompletedNCT06433440Phase 41 country
- Vaccine Prevention of Rabies Adopts 4-shot Immunization MethodCompletedNCT05549908Phase 31 country
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy AdultsCompletedNCT04062669Phase 11 country
- To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)CompletedNCT06177249Phase 31 country
- A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)Active, not recruitingNCT04852068Phase 31 country
- A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)CompletedNCT06078423Phase 31 country
- The Role of Fatty Acids in Vaccine EfficacyCompletedNCT05987384Not applicable1 country
- Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and IntradermallyCompletedNCT05937113Phase 41 country
- Responses to Rabies Vaccine in Adults With or Without AntibioticsCompletedNCT03557008Phase 41 country
- Integrating Community Interventions to Eliminate Neglected Tropical DiseasesCompletedNCT03667079Not applicable1 country
- Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1Status unknownNCT05832073Early Phase 11 country
- A Phase III Clinical Study to Evaluate SYN023's Efficacy and SafetyCompletedNCT04644484Phase 31 country
- Immunity Persistence After Abridged Intradermal Rabies PEPCompletedNCT04829630Not applicable2 countries